RUBICON RESEARCH LIMITED (RUBICON) Share Price rises 2.20% as stock gains today
- September 18, 2026
- Posted by: Harsh Piplani
- Category: News
RUBICON Share Price rose today, with the stock trading at Rs 1,816.20 after a 2.20% increase from the previous close of Rs 1,777.15. The company’s market capitalisation stood at Rs 29,195.69 crore, placing today’s move in a clearly measurable size context for RUBICON Research Limited. The session’s open was Rs 1,773.85, while the day’s high and low were Rs 1,824.85 and Rs 1,773.85, respectively. Turnover was Rs 1.3 crore. The supplied data confirms the price event, but it does not establish a company-specific catalyst, so this RUBICON Stock News note focuses on verified numbers, valuation context and the healthcare backdrop. For readers tracking RUBICON Share Price Today, the immediate questions are what changed in price action, how expensive the stock is on fundamentals, and how it compares with listed peers in Pharmaceuticals & Drugs. Univest is using the supplied data to frame that analysis without adding unsupported causes.
RUBICON Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,816.2 |
| Previous Close | Rs 1,777.15 |
| Today's Move | Rs 39.05 (+2.2%) |
| Open | Rs 1,773.85 |
| High | Rs 1,824.85 |
| Low | Rs 1,773.85 |
| Turnover | Rs 1.3 crore |
| Market Capitalisation | Rs 29,195.69 crore |
| Market Cap Category | Large Cap |
RUBICON RESEARCH LIMITED (RUBICON) rose to Rs 1,816.2 from the previous close of Rs 1,777.15, a move of Rs 39.05 or 2.2%. The stock opened at Rs 1,773.85, reached a high of Rs 1,824.85, recorded a low of Rs 1,773.85.
RUBICON Share Price Today reflected a positive same-day move of Rs 39.05. The stock opened at Rs 1,773.85, stayed within a range of Rs 1,773.85 to Rs 1,824.85, and ended at Rs 1,816.20 versus the previous close of Rs 1,777.15. That means RUBICON Share Price gained 2.20% during the session, making it one of the Stocks in News for the day. The available data confirms a higher close and a session range that remained relatively contained around the day’s opening level. Univest notes only the verified price rise and the associated market capitalisation, without attaching a catalyst that is not supplied. For anyone following RUBICON Share Price Live or RUBICON Share Price Update, the relevant facts are the exact price change, the current price, the open, the high, the low and the turnover reported for the session.
RUBICON RESEARCH LIMITED (RUBICON) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 29,195.69 crore |
| P/E Ratio | 102.07x |
| P/B Ratio | 21.92x |
| ROE | 27.84% |
| ROCE | 29.22% |
| EPS | Rs 17.41 |
| Book Value Per Share | Rs 81.09 |
| Dividend Yield | 0.08% |
RUBICON RESEARCH LIMITED (RUBICON) fundamental metrics show P/E 102.07x, P/B 21.92x, ROE 27.84%, ROCE 29.22%. These figures provide context only and are not a buy or sell signal.
RUBICON RESEARCH LIMITED has a market capitalisation of Rs 29195.69 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 102.07x, P/B at 21.92x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.84% and ROCE of 29.22%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 17.41, book value per share of Rs 81.09, dividend yield of 0.08%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.69x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 102.07x |
| Benchmark Median P/E | 32.69x |
| Benchmark Average P/E | 44.72x |
| Benchmark P/E Range | 3.44x to 417.17x |
| Company P/B Ratio | 21.92x |
| Benchmark Median P/B | 3.1x |
| Company ROE | 27.84% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 29.22% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 29,195.69 crore |
| Benchmark Median Market Cap | Rs 741.38 crore |
RUBICON RESEARCH LIMITED (RUBICON) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
RUBICON RESEARCH LIMITED (RUBICON) has a P/E ratio of 102.07x, which is above the benchmark median of 32.69x, a difference of +212.24%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
RUBICON RESEARCH LIMITED (RUBICON) has a ROE of 27.84%, which is above the benchmark median of 11.78%, a difference of +136.33%. RUBICON RESEARCH LIMITED (RUBICON) has a ROCE of 29.22%, which is above the benchmark median of 13.65%, a difference of +114.07%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 37.01 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,44,223.13 | 84.83 | 14.05 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,83,453.32 | 85.3 | 20.73 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,10,224.17 | 25.14 | 4.21 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,09,848.55 | 32.89 | 3.15 | 11.83 | 16 |
RUBICON RESEARCH LIMITED (RUBICON) has a P/E ratio of 102.07x compared with the displayed peer median of 37.01x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 27.84% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 29.22% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. RUBICON RESEARCH LIMITED (RUBICON) has a market capitalisation of Rs 29,195.69 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching RUBICON
- RUBICON Share Price rose 2.20% today to Rs 1,816.20, versus the previous close of Rs 1,777.15.
- The session range ran from Rs 1,773.85 to Rs 1,824.85, with turnover reported at Rs 1.3 crore.
- RUBICON’s market capitalisation stood at Rs 29,195.69 crore on the latest available data.
- The stock’s P/E ratio is 102.07 and P/B ratio is 21.92, both above the same-industry benchmark median and average.
- ROE is 27.84% and ROCE is 29.22%, both above the sector median and average in the supplied snapshot.
About RUBICON
RUBICON Research Limited is classified in Healthcare and the Pharmaceuticals & Drugs industry. The supplied data does not include a business-description note, so the company can be described only through this market classification and its valuation profile. For RUBICON Share Price readers, that means the visible evidence today is centred on the listed equity itself rather than on a detailed product or segment breakdown. Univest therefore keeps the company overview factual: the stock belongs to the pharmaceutical universe, is valued at Rs 29,195.69 crore in market cap terms, and shows profitability metrics that are stronger than the supplied sector median and average. This is the most reliable company context that can be drawn from the provided figures without adding assumptions. In RUBICON Stock News coverage, that is enough to explain the relevance of today’s price rise and why the stock remains part of broader healthcare and valuation discussions.
Track RUBICON Share Price on Univest
Use RUBICON RESEARCH LIMITED (RUBICON) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track RUBICON Share Price on Univest for live share price updates, stock news, fundamental ratios, shareholding pattern views, 52-week levels and broader market insights. Univest also presents company-level analysis in a format that helps readers compare RUBICON Share Price Today with sector peers, recent earnings context and market capitalisation trends. For investors searching RUBICON News Today, RUBICON Share News or RUBICON Latest News, the stock page brings together the verified price action and core financial ratios in one place. That makes it easier to follow RUBICON Stock Analysis, review RUBICON Fundamental Analysis and monitor future updates from the same source. Univest keeps the coverage factual and structured so readers can quickly revisit the most important metrics without having to search across multiple pages.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is RUBICON Share Price rising today?
Ans. The supplied data confirms that RUBICON Share Price rose 2.20% today, but it does not establish a company-specific catalyst. The move can be described only through the verified price, open, high, low, previous close and turnover.
What is RUBICON Share Price today?
Ans. RUBICON Share Price today is Rs 1,816.20. It rose Rs 39.05 from the previous close of Rs 1,777.15, and the session’s open was Rs 1,773.85. The previous close was Rs 1,777.15.
How much did RUBICON stock gain today?
Ans. RUBICON stock gained 2.20% in the session, which equals Rs 39.05. The stock traded between Rs 1,773.85 and Rs 1,824.85 during the day. The previous close was Rs 1,777.15. The stock moved 2.2% during the session.
What is RUBICON’s market capitalisation?
Ans. RUBICON’s market capitalisation is Rs 29,195.69 crore. That places the company well above the sector median and average in the supplied same-industry benchmark universe. The company operates in the Healthcare sector.
How does RUBICON compare on valuation with peers?
Ans. RUBICON’s P/E of 102.07 and P/B of 21.92 are higher than the listed peers shown here. Its ROE and ROCE are also stronger than the peer set in the supplied data.
Which sector does RUBICON belong to?
Ans. RUBICON belongs to Healthcare, within the Pharmaceuticals & Drugs industry. The sector snapshot compares it with 200 same-industry companies, making the benchmark context broad and relevant. The stock belongs to the Healthcare sector.
Can investors track RUBICON Share Price on Univest?
Ans. Yes. Univest tracks RUBICON Share Price with live updates, stock news, fundamental ratios, shareholding pattern views, 52-week levels and market insights in one structured stock page. The previous close was Rs 1,777.15.
